Artiva Biotherapeutics, Inc.ARTVNASDAQ
Loading
Operating Income Growth AcceleratingAccelerating
Percentile Rank82
Studio
Year-over-Year Change

Year-over-year operating income growth rate

Latest
0.72%
↑ 116% vs avg
Percentile
P82
Within normal range
Streak
3 qtr
Consecutive growthAccelerating
Average
-4.64%
Historical baseline
PeriodValue
Q4 20250.72%
Q3 2025-0.38%
Q2 2025-2.88%
Q1 2025-21.37%
Q4 20240.37%
Q3 2024-13.25%
Q2 2024-11.72%
Q1 2024-21.07%
Q4 2023-210.72%
Q3 2023191.43%
Q2 202333.15%
Q1 20230.00%